-
Notifications
You must be signed in to change notification settings - Fork 0
Commit
This commit does not belong to any branch on this repository, and may belong to a fork outside of the repository.
- Loading branch information
1 parent
bc998c9
commit 0609fba
Showing
20 changed files
with
265 additions
and
6 deletions.
There are no files selected for viewing
Binary file not shown.
Binary file not shown.
1 change: 1 addition & 0 deletions
1
assets/ASCCP_Management_Guidelines_August_2014_1730369900999_0.edn
This file contains bidirectional Unicode text that may be interpreted or compiled differently than what appears below. To review, open the file in an editor that reveals hidden Unicode characters.
Learn more about bidirectional Unicode characters
Original file line number | Diff line number | Diff line change |
---|---|---|
@@ -0,0 +1 @@ | ||
{:highlights [], :extra {:page 5}} |
Binary file not shown.
Empty file.
This file contains bidirectional Unicode text that may be interpreted or compiled differently than what appears below. To review, open the file in an editor that reveals hidden Unicode characters.
Learn more about bidirectional Unicode characters
Original file line number | Diff line number | Diff line change |
---|---|---|
@@ -0,0 +1 @@ | ||
- ![ASCCP Management Guidelines_August 2014.pdf](../assets/ASCCP_Management_Guidelines_August_2014_1730369900999_0.pdf) |
This file contains bidirectional Unicode text that may be interpreted or compiled differently than what appears below. To review, open the file in an editor that reveals hidden Unicode characters.
Learn more about bidirectional Unicode characters
Original file line number | Diff line number | Diff line change |
---|---|---|
@@ -0,0 +1,70 @@ | ||
- alias:: | ||
ICD-11_Code:: | ||
- ## Etiology | ||
background-color:: blue | ||
- ### Causative Agents | ||
- ### Risk Factors | ||
- ## Epidemiology | ||
background-color:: blue | ||
- ### Incidence | ||
- ### Prevalence | ||
- ### Demographics | ||
- ### Geographic Distribution | ||
- ## Pathophysiology | ||
background-color:: blue | ||
- ### Mechanism of Disease | ||
- ### Affected Systems/Organs | ||
- ## Clinical Features | ||
background-color:: blue | ||
- ### Signs and Symptoms | ||
- #### Symptoms | ||
- #### Signs | ||
- ### Stages or Classification | ||
- ### Diagnostic Criteria | ||
- ## Diagnosis | ||
background-color:: blue | ||
- ### Clinical Diagnosis | ||
- ### Laboratory Tests | ||
- ### Imaging Studies | ||
- ### Differential Diagnosis | ||
- ## Management and Treatment | ||
background-color:: blue | ||
- ### Medical Treatment | ||
- ### Surgical Options | ||
- ### Lifestyle and Dietary Recommendations | ||
- ## Prognosis | ||
background-color:: blue | ||
- ### Expected Course | ||
- #### With Treatment | ||
- #### Without Treatment | ||
- ### Survival Rates | ||
- #### With Treatment | ||
- #### Without Treatment | ||
- ### Quality of Life Considerations | ||
- ## Complications | ||
background-color:: blue | ||
- ### Possible Complications | ||
- ### Long-term Effects | ||
- ## Prevention | ||
background-color:: blue | ||
- ### Health Education | ||
- ### Community Approach | ||
- ### Screening Programs | ||
source:: ACOG | ||
- Begin at age 40 ending at age 75 | ||
exception:: start early if risk factors | ||
- Annual Breast Exam : Annual Mammogram | ||
- ### Lifestyle Modifications | ||
- ## Patient Education and Support | ||
background-color:: blue | ||
- ### Educational Resources | ||
- ### Support Groups | ||
- ### Counseling Options | ||
- ## Recent Research and Developments | ||
background-color:: blue | ||
- ### Ongoing Clinical Trials | ||
- ### Recent Advances | ||
- ## Key Literature | ||
background-color:: blue | ||
- ## Guidelines and Protocols | ||
background-color:: blue |
This file contains bidirectional Unicode text that may be interpreted or compiled differently than what appears below. To review, open the file in an editor that reveals hidden Unicode characters.
Learn more about bidirectional Unicode characters
Original file line number | Diff line number | Diff line change |
---|---|---|
@@ -0,0 +1,5 @@ | ||
- [[Cervical Carcinoma]] | ||
- [[Breast Cancer]] | ||
- Refer to [[PCP]] | ||
- [[Colon Cancer]] | ||
- [[Lung Cancer]] |
This file contains bidirectional Unicode text that may be interpreted or compiled differently than what appears below. To review, open the file in an editor that reveals hidden Unicode characters.
Learn more about bidirectional Unicode characters
This file contains bidirectional Unicode text that may be interpreted or compiled differently than what appears below. To review, open the file in an editor that reveals hidden Unicode characters.
Learn more about bidirectional Unicode characters
Original file line number | Diff line number | Diff line change |
---|---|---|
@@ -0,0 +1,71 @@ | ||
- alias:: | ||
ICD-11_Code:: | ||
- ## Etiology | ||
background-color:: blue | ||
- ### Causative Agents | ||
- ### Risk Factors | ||
- ## Epidemiology | ||
background-color:: blue | ||
- ### Incidence | ||
- ### Prevalence | ||
- ### Demographics | ||
- ### Geographic Distribution | ||
- ## Pathophysiology | ||
background-color:: blue | ||
- ### Mechanism of Disease | ||
- ### Affected Systems/Organs | ||
- ## Clinical Features | ||
background-color:: blue | ||
- ### Signs and Symptoms | ||
- #### Symptoms | ||
- #### Signs | ||
- ### Stages or Classification | ||
- ### Diagnostic Criteria | ||
- ## Diagnosis | ||
background-color:: blue | ||
- ### Clinical Diagnosis | ||
- ### Laboratory Tests | ||
- ### Imaging Studies | ||
- ### Differential Diagnosis | ||
- ## Management and Treatment | ||
background-color:: blue | ||
- ### Medical Treatment | ||
- ### Surgical Options | ||
- ### Lifestyle and Dietary Recommendations | ||
- ## Prognosis | ||
background-color:: blue | ||
- ### Expected Course | ||
- #### With Treatment | ||
- #### Without Treatment | ||
- ### Survival Rates | ||
- #### With Treatment | ||
- #### Without Treatment | ||
- ### Quality of Life Considerations | ||
- ## Complications | ||
background-color:: blue | ||
- ### Possible Complications | ||
- ### Long-term Effects | ||
- ## Prevention | ||
background-color:: blue | ||
- ### Health Education | ||
- ### Community Approach | ||
- ### Screening Programs | ||
- Begin at age : 50 | ||
exception:: if 1st degree relative with colon cancer, then begin 10 years prior to the youngest known diagnosis in the family or age 40 whichever is earlier | ||
- Colonoscopy | ||
- [[FOBT]] | ||
- FIT | ||
- ### Lifestyle Modifications | ||
- ## Patient Education and Support | ||
background-color:: blue | ||
- ### Educational Resources | ||
- ### Support Groups | ||
- ### Counseling Options | ||
- ## Recent Research and Developments | ||
background-color:: blue | ||
- ### Ongoing Clinical Trials | ||
- ### Recent Advances | ||
- ## Key Literature | ||
background-color:: blue | ||
- ## Guidelines and Protocols | ||
background-color:: blue |
This file contains bidirectional Unicode text that may be interpreted or compiled differently than what appears below. To review, open the file in an editor that reveals hidden Unicode characters.
Learn more about bidirectional Unicode characters
Original file line number | Diff line number | Diff line change |
---|---|---|
@@ -0,0 +1 @@ | ||
alias:: FOBT |
This file contains bidirectional Unicode text that may be interpreted or compiled differently than what appears below. To review, open the file in an editor that reveals hidden Unicode characters.
Learn more about bidirectional Unicode characters
This file contains bidirectional Unicode text that may be interpreted or compiled differently than what appears below. To review, open the file in an editor that reveals hidden Unicode characters.
Learn more about bidirectional Unicode characters
Original file line number | Diff line number | Diff line change |
---|---|---|
@@ -1,4 +1,15 @@ | ||
- [[Mentruation]] | ||
- [[Fibroid Uterus]] | ||
- [[Abnormal Uterine Bleeding]] | ||
- | ||
- [[Cancers in Gynaecology]] | ||
- [[Vaccinations in Gyanaecology]] | ||
- SOE | ||
- LATER 1 | ||
- LATER 2 | ||
- LATER 3 | ||
- LATER 4 | ||
- LATER 6 | ||
- LATER 7 | ||
- LATER 8 | ||
- LATER 9 | ||
- LATER 10 |
This file contains bidirectional Unicode text that may be interpreted or compiled differently than what appears below. To review, open the file in an editor that reveals hidden Unicode characters.
Learn more about bidirectional Unicode characters
This file contains bidirectional Unicode text that may be interpreted or compiled differently than what appears below. To review, open the file in an editor that reveals hidden Unicode characters.
Learn more about bidirectional Unicode characters
This file contains bidirectional Unicode text that may be interpreted or compiled differently than what appears below. To review, open the file in an editor that reveals hidden Unicode characters.
Learn more about bidirectional Unicode characters
Original file line number | Diff line number | Diff line change |
---|---|---|
@@ -0,0 +1,67 @@ | ||
- alias:: | ||
ICD-11_Code:: | ||
- ## Etiology | ||
background-color:: blue | ||
- ### Causative Agents | ||
- ### Risk Factors | ||
- ## Epidemiology | ||
background-color:: blue | ||
- ### Incidence | ||
- ### Prevalence | ||
- ### Demographics | ||
- ### Geographic Distribution | ||
- ## Pathophysiology | ||
background-color:: blue | ||
- ### Mechanism of Disease | ||
- ### Affected Systems/Organs | ||
- ## Clinical Features | ||
background-color:: blue | ||
- ### Signs and Symptoms | ||
- #### Symptoms | ||
- #### Signs | ||
- ### Stages or Classification | ||
- ### Diagnostic Criteria | ||
- ## Diagnosis | ||
background-color:: blue | ||
- ### Clinical Diagnosis | ||
- ### Laboratory Tests | ||
- ### Imaging Studies | ||
- ### Differential Diagnosis | ||
- ## Management and Treatment | ||
background-color:: blue | ||
- ### Medical Treatment | ||
- ### Surgical Options | ||
- ### Lifestyle and Dietary Recommendations | ||
- ## Prognosis | ||
background-color:: blue | ||
- ### Expected Course | ||
- #### With Treatment | ||
- #### Without Treatment | ||
- ### Survival Rates | ||
- #### With Treatment | ||
- #### Without Treatment | ||
- ### Quality of Life Considerations | ||
- ## Complications | ||
background-color:: blue | ||
- ### Possible Complications | ||
- ### Long-term Effects | ||
- ## Prevention | ||
background-color:: blue | ||
- ### Health Education | ||
- ### Community Approach | ||
- ### Screening Programs | ||
- age : 55-80 with 30 pack-year, annual low-dose CT | ||
- ### Lifestyle Modifications | ||
- ## Patient Education and Support | ||
background-color:: blue | ||
- ### Educational Resources | ||
- ### Support Groups | ||
- ### Counseling Options | ||
- ## Recent Research and Developments | ||
background-color:: blue | ||
- ### Ongoing Clinical Trials | ||
- ### Recent Advances | ||
- ## Key Literature | ||
background-color:: blue | ||
- ## Guidelines and Protocols | ||
background-color:: blue |
This file contains bidirectional Unicode text that may be interpreted or compiled differently than what appears below. To review, open the file in an editor that reveals hidden Unicode characters.
Learn more about bidirectional Unicode characters
Original file line number | Diff line number | Diff line change |
---|---|---|
@@ -0,0 +1 @@ | ||
alias:: PCP |
This file contains bidirectional Unicode text that may be interpreted or compiled differently than what appears below. To review, open the file in an editor that reveals hidden Unicode characters.
Learn more about bidirectional Unicode characters
This file contains bidirectional Unicode text that may be interpreted or compiled differently than what appears below. To review, open the file in an editor that reveals hidden Unicode characters.
Learn more about bidirectional Unicode characters
Original file line number | Diff line number | Diff line change |
---|---|---|
@@ -0,0 +1,8 @@ | ||
- HPV: 3 dose series age 12-26 | ||
- Influenza: annual | ||
- Pneumovax: 1 dose and 1 booster any age if risk factors. After age 65 if no risk factors | ||
- Shingles: 2 dose age 50+ | ||
- Hep B: initial vaccination in youth, vaccination for anyone non-immune | ||
- MMR: if not immune | ||
- Varicella: if not immune | ||
- Tdap: Booster at 10yrs, new parents |
2 changes: 2 additions & 0 deletions
2
pages/hls__ASCCP_Management_Guidelines_August_2014_1730369900999_0.md
This file contains bidirectional Unicode text that may be interpreted or compiled differently than what appears below. To review, open the file in an editor that reveals hidden Unicode characters.
Learn more about bidirectional Unicode characters
Original file line number | Diff line number | Diff line change |
---|---|---|
@@ -0,0 +1,2 @@ | ||
file:: [ASCCP_Management_Guidelines_August_2014_1730369900999_0.pdf](../assets/ASCCP_Management_Guidelines_August_2014_1730369900999_0.pdf) | ||
file-path:: ../assets/ASCCP_Management_Guidelines_August_2014_1730369900999_0.pdf |